Publication | Closed Access

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines

OncologyMedicineBronchial NeoplasmTyrosine Kinase InhibitorsAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyLung CancerTumor BiologyCancer GrowthMdr-substrate Anticancer Agents